293 related articles for article (PubMed ID: 36595859)
1. A prognostic risk prediction model based on ferroptosis-related long non-coding RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation.
Xiang X; Guo Y; Chen Z; Zhang F; Huang J; Qin Y
Medicine (Baltimore); 2022 Dec; 101(51):e32558. PubMed ID: 36595859
[TBL] [Abstract][Full Text] [Related]
2. Accurate prognostic prediction for patients with clear cell renal cell carcinoma using a ferroptosis-related long non-coding RNA risk model.
Xiang X; Guo Y; Chen Z; Zhang F; Qin Y
Cancer Biomark; 2023; 37(2):95-107. PubMed ID: 37248883
[TBL] [Abstract][Full Text] [Related]
3. A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients.
Chen M; Nie Z; Li Y; Gao Y; Wen X; Cao H; Zhang S
Front Cell Dev Biol; 2021; 9():699804. PubMed ID: 34869304
[No Abstract] [Full Text] [Related]
4. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
[TBL] [Abstract][Full Text] [Related]
5. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
[TBL] [Abstract][Full Text] [Related]
6. A prognostic signature based on the expression profile of the ferroptosis-related long non-coding RNAs in hepatocellular carcinoma.
Lin X; Yang S
Adv Clin Exp Med; 2022 Oct; 31(10):1099-1109. PubMed ID: 35581934
[TBL] [Abstract][Full Text] [Related]
7. Identification of Ferroptosis-Associated Long Noncoding RNA Prognostic Model and Tumor Immune Microenvironment in Thyroid Cancer.
Lin Y; Gan F; He X; Deng H; Li Y
J Immunol Res; 2022; 2022():5893998. PubMed ID: 35915656
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer.
Cai HJ; Zhuang ZC; Wu Y; Zhang YY; Liu X; Zhuang JF; Yang YF; Gao Y; Chen B; Guan GX
Bosn J Basic Med Sci; 2021 Oct; 21(5):569-576. PubMed ID: 33714257
[TBL] [Abstract][Full Text] [Related]
9. A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer.
Wei J; Zeng Y; Gao X; Liu T
BMC Cancer; 2021 Nov; 21(1):1221. PubMed ID: 34774009
[TBL] [Abstract][Full Text] [Related]
10. Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment.
Wang Y; Lu G; Xue X; Xie M; Wang Z; Ma Z; Feng Y; Shao C; Duan H; Pan M; Ding P; Li X; Han J; Yan X
Front Immunol; 2022; 13():903758. PubMed ID: 36016939
[TBL] [Abstract][Full Text] [Related]
11. A prognostic risk prediction model based on ferroptosis-related long non-coding RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation: Erratum.
Medicine (Baltimore); 2024 Mar; 103(11):e37547. PubMed ID: 38489743
[No Abstract] [Full Text] [Related]
12. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer.
Tan Z; Fu S; Zuo J; Wang J; Wang H
Aging (Albany NY); 2023 Aug; 15(16):8384-8407. PubMed ID: 37632832
[TBL] [Abstract][Full Text] [Related]
13. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
14. A novel ferroptosis-related long noncoding RNA signature for relapse free survival prediction in patients with breast cancer.
Wang Y; Xu Y; Zhang Y
Medicine (Baltimore); 2022 Aug; 101(31):e29573. PubMed ID: 35945765
[TBL] [Abstract][Full Text] [Related]
15. A Novel Aging-Related Prognostic lncRNA Signature Correlated with Immune Cell Infiltration and Response to Immunotherapy in Breast Cancer.
Liu Z; Ren C; Cai J; Yin B; Yuan J; Ding R; Ming W; Sun Y; Li Y
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110517
[TBL] [Abstract][Full Text] [Related]
16. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
Cao J; Liang Y; Gu JJ; Huang Y; Wang B
Front Genet; 2022; 13():991162. PubMed ID: 36353118
[No Abstract] [Full Text] [Related]
17. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
Lu H; Wu J; Liang L; Wang X; Cai H
Front Immunol; 2022; 13():803355. PubMed ID: 35154117
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
19. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
Front Immunol; 2022; 13():916800. PubMed ID: 35860239
[TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer.
Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C
Front Immunol; 2021; 12():783362. PubMed ID: 35154072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
